Want help reviewing this study?
Study ID: NCT06803485. We help you review the study, but cannot decide medical eligibility.
RecruitingNCT06803485
Venlafaxine for Somatic Symptom Disorder
The registry lists this study as recruiting. Study locations are listed in India. Confirm recruitment at each site. It is testing venlafaxine for Somatic Symptom Disorder.
Somatic symptom disorders, Somatic Symptom Disorder (DSM-V)DrugFrom 18 Years to 65 Years
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
- Listed locations
- Bhubaneswar, IndiaSee all locations and recruitment
Compensation and expense reimbursement have not been verified for this summary.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: March 11, 2025
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 84
- Sponsor
- All India Institute of Medical Sciences, Bhubaneswar
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- India
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT06803485
- Official title
- Effect of Venlafaxine Versus Dosulepin on Clinical Outcomes, Neuroinflammation and Cortisol Level in Pain Predominant Somatic Symptom Disorder: A Group-sequential Randomized Controlled Trial
Recruitment & locations
RecruitingBhubaneswar
Registry details
Registry conditions (original wording)
Somatic Symptom Disorder (DSM-V)
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is All India Institute of Medical Sciences, Bhubaneswar, a research institute.
Does this study involve medication?
Yes. The study involves medication, including Venlafaxine and Dosulepin.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as recruiting.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
RecruitingNCT04899687
Dextromethorphan in OCD and Related Disorders
This study is recruiting. It focuses on somatic symptom disorders and currently lists participation information in the United States.
RecruitingNCT07286175
Brenipatide in adults with Bipolarity (RENEW-Bipolar-1)
The registry lists this study as recruiting. Study locations are listed in the United States, in Argentina, in Brazil, ... Confirm recruitment at each site. It is testing brenipatide for Bipolarity.
RecruitingNCT07410507
Brenipatide in adults with Schizophrenia
The registry lists this study as recruiting. Study locations are listed in the United States, in Argentina, in Brazil, ... Confirm recruitment at each site. It is testing brenipatide for schizophrenia.